Financials

  • Market Capitalization 7.975 B
  • Employee 423
  • Founded 1998
  • CEO Helen I. Torley
  • Website www.halozyme.com
  • Headquarter Delaware, United States
  • FIGI BBG000CZ8W54
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
26.29
売上高対価格比率
5.97

Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

ニュース